GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Compound class:
Endogenous peptide in human, mouse or rat
Comment: Interleukin 18 binding protein (IL18BP) binds to and inhibits the activity of circulating pro-inflammatory IL-18 at its receptor [3].
Synthetic IL18BP mimetics offer potential anti-inflammatory action for the treatment of inflammation-mediated (and autoimmune) diseases [1-2].
Species: Human
|
References |
1. Jang YS, Lee K, Park M, Joo Park J, Choi GM, Kim C, Dehkohneh SB, Chi S, Han J, Song MY et al.. (2023)
Albumin-binding recombinant human IL-18BP ameliorates macrophage activation syndrome and atopic dermatitis via direct IL-18 inactivation. Cytokine, 172: 156413. [PMID:37918054] |
2. Novick D. (2024)
IL-18 and IL-18BP: A Unique Dyad in Health and Disease. Int J Mol Sci, 25 (24). [PMID:39769266] |
3. Park SY, Hisham Y, Shin HM, Yeom SC, Kim S. (2022)
Interleukin-18 Binding Protein in Immune Regulation and Autoimmune Diseases. Biomedicines, 10 (7). [PMID:35885055] |